Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
alpha 1H, Placebo product for Alpha1H
Lacuna Pharma Pty Ltd
Non-muscle invasive bladder cancer awaiting transurethral surgery
1 trial -
placebo
Nektar Therapeutics UK Limited
Opioid Induced Constipation (OIC)
1 trial -
placebo
The First People's Hospital of Lianyungang
COVID-19 Thalidomide
1 trial -
placebo
Universal Integrated
Postprandial Distress Syndrome
1 trial -
placebo mouthwash
BRIGHT MINDS BIOSCIENCES INC.
Dentinal Hypersensitivity
1 trial -
placebo of BAY 3427080, BAY 3427080
Bayer AG
Sleep disturbances associated with menopause
1 trial -
telaprevir or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
tulisokibart, Placebo to MK-7240
Merck Sharp and Dohme
Psoriatic arthritis
1 trial -
tulisokibart, Placebo to MK-7240 (tulisokibart)
Merck Sharp and Dohme
Rheumatoid Arthritis
1 trial -
A clinical study of MK-5661 and placebo in healthy people (MK-5661-006)
Merck Sharp and Dohme
Pain
1 trial -
A clinical study of MK-6916 and placebo in healthy people (MK-6916-003)
Merck Sharp and Dohme
Acute and chronic Pain
1 trial -
A randomized double-blind placebo-controlled... for Circulatory shock
Lacuna Pharma Pty Ltd
Circulatory shock
1 trial -
AK120 or placebo- Part 1- Cohort 1
Akeso
Atopic Dermatitis
1 trial -
Amoxicillin + MMX placebo
Takeda
Healthy
1 trial -
Ciprofloxacin XR + MMX Placebo
Takeda
Healthy
1 trial -
ETC-1002 or placebo
Esperion Therapeutics
Mild Dyslipidemia
1 trial -
Epetraborole and matching placebo
AN2 Therapeutics
Healthy Volunteers
1 trial -
FTX-6058/placebo oral capsule(s)
Fulcrum Therapeutics
Healthy Adult Subjects
1 trial -
HY-2003 (10 mg/ml), BELKYRA and placebo
The First People's Hospital of Lianyungang
Moderate or Severe Submental Fullness
1 trial -
Ixazomib (NINLARO®) capsules / Matching placebo capsules
Takeda
Relapsing Remitting Multiple Sclerosis
1 trial -
KT-474/Placebo
Kymera Therapeutics
Healthy Volunteer
1 trial -
MT203 80 mg or matching Placebo
Takeda
Healthy Volunteers
1 trial -
Metronidazole + MMX Mesalazine/mesalamine placebo
Takeda
Healthy
1 trial -
PF-07868489 Placebo, PF-07868489
Pfizer Australia Pty Ltd
Pulmonary Arterial Hypertension
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.